2021 American College of Rheumatology Guideline for the Treatment of Juvenile Idiopathic Arthritis: Recommendations for Nonpharmacologic Therapies, Medication Monitoring, Immunizations, and Imaging.
Karen B OnelDaniel B HortonDaniel J LovellSusan ShenoiCarlos A CuelloSheila T Angeles-HanMara L BeckerRandy Q CronBrian M FeldmanPolly J FergusonHarry GewanterJaime GuzmanYukiko KimuraTzielan LeeKatherine MurphyPeter A NigrovicMichael J OmbrelloC Egla RabinovichMelissa S TesherMarinka TwiltMarisa Klein-GitelmanFatima Barbar-SmileyAshley M CooperBarbara EdelheitMiriah Gillispie-TaylorKimberly HaysMelissa L MannionRosemary G PetersonElaine FlanaganNadine SaadNancy SullivanAnn Marie SzymanskiRebecca TrachtmanMarat TurgunbaevKeila VeigaAmy S TurnerJames T RestonPublished in: Arthritis care & research (2022)
This clinical practice guideline complements the 2019 American College of Rheumatology JIA and uveitis guidelines, which addressed polyarthritis, sacroiliitis, enthesitis, and uveitis, and a concurrent 2021 guideline on oligoarthritis, temporomandibular arthritis, and systemic JIA. It serves as a tool to support clinicians, patients, and caregivers in decision-making. The recommendations take into consideration the severity of both articular and nonarticular manifestations as well as patient quality of life. Although evidence is generally low quality and many recommendations are conditional, the inclusion of caregivers and patients in the decision-making process strengthens the relevance and applicability of the guideline. It is important to remember that these are recommendations. Clinical decisions, as always, should be made by the treating clinician and patient/caregiver.
Keyphrases
- juvenile idiopathic arthritis
- end stage renal disease
- decision making
- disease activity
- clinical practice
- chronic kidney disease
- ejection fraction
- newly diagnosed
- healthcare
- peritoneal dialysis
- rheumatoid arthritis
- high resolution
- case report
- squamous cell carcinoma
- radiation therapy
- systemic lupus erythematosus
- patient reported
- combination therapy
- rectal cancer
- electronic health record
- drug induced